These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7780131)

  • 1. Inhibition of endotoxin-induced activation of the coagulation and fibrinolytic pathways using a recombinant endotoxin-binding protein (rBPI23).
    von der Möhlen MA; van Deventer SJ; Levi M; van den Ende B; Wedel NI; Nelson BJ; Friedmann N; ten Cate JW
    Blood; 1995 Jun; 85(12):3437-43. PubMed ID: 7780131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant endotoxin-binding protein (rBPI23) attenuates endotoxin-induced circulatory changes in humans.
    de Winter RJ; von der Möhlen MA; van Lieshout H; Wedel N; Nelson B; Friedmann N; Delemarre BJ; van Deventer SJ
    J Inflamm; 1995; 45(3):193-206. PubMed ID: 8597874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.
    de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van Der Poll T
    Blood; 2000 Feb; 95(4):1124-9. PubMed ID: 10666180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. rBPI23 attenuates endotoxin-induced cardiovascular depression in awake rabbits.
    Koyama S; Shibamoto T; Ammons WS; Saeki Y
    Shock; 1995 Jul; 4(1):74-8. PubMed ID: 7552782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein.
    von der Möhlen MA; Kimmings AN; Wedel NI; Mevissen ML; Jansen J; Friedmann N; Lorenz TJ; Nelson BJ; White ML; Bauer R
    J Infect Dis; 1995 Jul; 172(1):144-51. PubMed ID: 7797904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades.
    Biemond BJ; Levi M; Ten Cate H; Van der Poll T; Büller HR; Hack CE; Ten Cate JW
    Clin Sci (Lond); 1995 May; 88(5):587-94. PubMed ID: 7614818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
    Levi M; ten Cate H; Bauer KA; van der Poll T; Edgington TS; Büller HR; van Deventer SJ; Hack CE; ten Cate JW; Rosenberg RD
    J Clin Invest; 1994 Jan; 93(1):114-20. PubMed ID: 8282778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fat emulsion infusion potentiates coagulation activation during human endotoxemia.
    van der Poll T; Coyle SM; Levi M; Boermeester MA; Braxton CC; Jansen PM; Hack CE; Lowry SF
    Thromb Haemost; 1996 Jan; 75(1):83-6. PubMed ID: 8713784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia.
    Pajkrt D; Lerch PG; van der Poll T; Levi M; Illi M; Doran JE; Arnet B; van den Ende A; ten Cate JW; van Deventer SJ
    Thromb Haemost; 1997 Feb; 77(2):303-7. PubMed ID: 9157586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin-10 response in human endotoxemia.
    de Pont AC; Moons AH; de Jonge E; Meijers JC; Vlasuk GP; Rote WE; Büller HR; van der Poll T; Levi M
    J Thromb Haemost; 2004 Jan; 2(1):65-70. PubMed ID: 14717968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colistin dampens fibrinolysis and endothelial activation during endotoxaemia. A randomised, double blind trial.
    Schoergenhofer C; Matzneller P; Mußbacher M; Schmid JA; Jilma-Stohlawetz P; Zeitlinger M; Jilma B
    Thromb Haemost; 2017 Aug; 117(9):1714-1721. PubMed ID: 28796276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant tumor necrosis factor receptor p75 fusion protein (TNFR:Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humans.
    DeLa Cadena RA; Majluf-Cruz A; Stadnicki A; Tropea M; Reda D; Agosti JM; Colman RW; Suffredini AF
    Thromb Haemost; 1998 Jul; 80(1):114-8. PubMed ID: 9684796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteers.
    Schoergenhofer C; Buchtele N; Gelbenegger G; Derhaschnig U; Firbas C; Kovacevic KD; Schwameis M; Wohlfarth P; Rabitsch W; Jilma B
    Sci Rep; 2019 Jul; 9(1):11136. PubMed ID: 31366975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic changes and systemic activation of coagulation and fibrinolysis during controlled endotoxemia in pigs.
    Kutzsche S; Schlichting E; Aspelin T; Lyberg T
    Thromb Res; 2000 Jun; 98(6):517-29. PubMed ID: 10899351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
    Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
    Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lepirudin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen JB; Stohlawetz P; Eichler HG; Handler S; Speiser W; Jilma B
    Blood; 2000 Mar; 95(5):1729-34. PubMed ID: 10688831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans.
    Jilma B; Marsik C; Mayr F; Graninger MT; Taylor FB; Ribel MC; Erhardtsen E; Handler S; Eichler HG
    Clin Pharmacol Ther; 2002 Oct; 72(4):403-10. PubMed ID: 12386642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen J; Knechtelsdorfer M; Stohlawetz P; Graninger W; Eichler HG; Speiser W; Jilma B
    Circulation; 1999 Dec 21-28; 100(25):2485-90. PubMed ID: 10604885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects.
    Suffredini AF; Harpel PC; Parrillo JE
    N Engl J Med; 1989 May; 320(18):1165-72. PubMed ID: 2496309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa.
    Biemond BJ; Levi M; ten Cate H; Soule HR; Morris LD; Foster DL; Bogowitz CA; van der Poll T; Büller HR; ten Cate JW
    Thromb Haemost; 1995 Feb; 73(2):223-30. PubMed ID: 7792734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.